AORT: Bullish Pennant detected on 5 Aug 2026

AORT has formed a bullish pennant pattern with the stock currently at $26.90, consolidated between support at $21.30 and resistance at $28.29. Pattern quality scores are solid: structure (13.0/15), volume (12.0/12), and breakout (12.0/13) indicate a well-defined consolidation with healthy relative volume at 1.05x average. The overall pattern score of 78 reflects a moderately attractive setup. RSI at 60.38 is neutral—neither overbought nor oversold. The stock sits 40.4% above its 52-week low of $19.16, positioning it for a potential measured move to $28.91 on confirmation.

Artivion's Q2 2026 earnings release is scheduled for Thursday, August 6, 2026, after market close, with a teleconference call at 4:30 p.m. ET—critical timing given this pattern detection on August 5. Analysts expect Q2 earnings of $0.0088 per share and revenue of $120.0170 million. In late June 2026, Artivion received FDA premarket approval for its AMDS Hybrid Prosthesis for acute aortic dissections with malperfusion, opening a US$150 million annual market. However, the company was removed from multiple Russell indices in late June 2026, which can affect trading liquidity and share volatility. Additionally, Artivion will present at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026, and hold investor meetings at the Needham MedTech Conference on August 11. The pennant forms ahead of earnings volatility and management engagement opportunities.

A breakout above $28.29 resistance on above-average volume would confirm the bullish pennant, with a measured move target of $28.91 (conservative estimate). Win probability stands at 60.28%, indicating slightly better than even odds. Volume confirmation would require relative volume above 1.3x on the breakout day. The pattern invalidates below the key support level of $21.30—a breakdown below that level negates the bullish thesis and signals deeper weakness. With beta of 0.67, AORT exhibits lower volatility relative to the market, which may result in a more measured, sustained move rather than explosive expansion.

Earnings release on August 6 immediately after pattern detection creates elevated binary risk—guidance misses or revenue shortfalls could trigger sharp sell-offs below the pennant structure. The company's recent Russell index exclusion reduces systematic buying pressure and may weigh on liquidity. Three-month performance shows a decline of -24.29%, indicating macro or fundamental headwinds despite the recent one-month gain of 9.08%. While the sector (Health Care) trades in a bullish regime (score 0.52), AORT itself is trading -44.25% below its 52-week high of $48.25, suggesting residual selling pressure. ATR of 1.04 (3.87% daily move) indicates moderate volatility—earnings could easily swing the stock ±4-5% in a single session, potentially breaking both support and resistance levels.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.